Fluorescein-Functionalized Iridium(III) Complexes as Dual-Mode Type I Photosensitizers for Hypoxia-Tolerant Photodynamic and X-ray-Induced Therapy
Inorganic Chemistry · 09.06.2025 · 64 (22) · 10894-10905
DOI: 10.1021/acs.inorgchem.5c00894 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inorganic Chemistry, online erschienen am 27.05.2025. Verfasst von Ji-Qiang Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Southern University of Science and Technology, 1088 Xueyuan Boulevard, Shenzhen 518055, China. Hauptthemen laut MEDLINE: Photosensitizing Agents, Photochemotherapy, Fluorescein, Iridium. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Science and Technology Foundation of Shenzhen City, Science, Technology and Innovation Commission of Shenzhen Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
The development of photosensitizers that function effectively in hypoxic environments and enable deep-tissue treatment remains a significant challenge in photodynamic therapy (PDT). Here, we report two novel Ir(III) complexes functionalized with fluorescein designed as efficient Type I photosensitizers for both light-driven PDT and X-ray-induced PDT (X-PDT). By populating the triplet state of the fluorescein ligands, these complexes facilitate the generation of reactive oxygen species (ROS) through electron transfer, producing superoxide anion radicals (O2•-) and hydroxyl radicals (•OH) under irradiation. The complexes exhibit pronounced phototoxicity against cancer cells, particularly under hypoxic conditions, where oxygen-dependent Type II photosensitizers are less effective. Remarkably, these complexes also demonstrate direct X-ray activation, offering a solution for deep-tissue cancer treatment. The lead complex, PS1, outperforms existing systems by efficiently generating both singlet oxygen O2(1Δg) and free radicals, enabling synergistic Type I and II PDT effects. This work represents a major advancement in the design of oxygen-independent PDT agents by using fluorescein's triplet state, with potential applications in deep-tissue and hypoxic tumor environments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Southern University of Science and Technology, 1088 Xueyuan Boulevard, Shenzhen 518055, China.
- Department of Chemistry, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR 999077, China.
- Guangdong Key Laboratory of Nanomedicine, Shenzhen Engineering Laboratory of Nanomedicine and Nanoformulations, CAS Key Laboratory for Health Informatics, Shenzhen Institutes of Advanced Technology, Chinese Academy of S…
- Department of Biochemistry and Microbiology, University of Chemistry and Technology, Technická 5, 166 28 Prague, Czech Republic.
- Division of Life Science, The Hong Kong University of Science and Technology, Hong Kong SAR 999077, China.
- Institute of Inorganic Chemistry of the Czech Academy of Sciences, Řež 1001, 250 68 Husinec-Řež, Czech Republic.
ORCID-Profile: Tomáš Ruml, Jaroslav Zelenka, Kaplan Kirakci, Kamil Lang, Chi-Sing Lee, Keith Man-Chung Wong
Förderung
- Science and Technology Foundation of Shenzhen City
- Science, Technology and Innovation Commission of Shenzhen Municipality
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Liu, J. Q., Tse, A. K., Koncošová, M., Ruml, T., Tse, Y. C., Liu, C. J., Zelenka, J., Kirakci, K., Lang, K., Lee, C. S., & Wong, K. M. (2025). Fluorescein-Functionalized Iridium(III) Complexes as Dual-Mode Type I Photosensitizers for Hypoxia-Tolerant Photodynamic and X-ray-Induced Therapy. Inorganic Chemistry, 64(22), 10894-10905. https://doi.org/10.1021/acs.inorgchem.5c00894
Vancouver
Liu JQ, Tse AK, Koncošová M, Ruml T, Tse YC, Liu CJ, et al. Fluorescein-Functionalized Iridium(III) Complexes as Dual-Mode Type I Photosensitizers for Hypoxia-Tolerant Photodynamic and X-ray-Induced Therapy. Inorganic Chemistry. 2025;64(22):10894-10905. doi:10.1021/acs.inorgchem.5c00894
BibTeX
@article{Liu2025,
author = {Liu, Ji-Qiang and Tse, Anfernee Kai-Wing and Koncošová, Martina and Ruml, Tomáš and Tse, Yu-Chung and Liu, Chuang-Jun and Zelenka, Jaroslav and Kirakci, Kaplan and Lang, Kamil and Lee, Chi-Sing and Wong, Keith Man-Chung},
title = {Fluorescein-Functionalized Iridium(III) Complexes as Dual-Mode Type I Photosensitizers for Hypoxia-Tolerant Photodynamic and X-ray-Induced Therapy},
journal = {Inorganic Chemistry},
year = {2025},
volume = {64},
number = {22},
pages = {10894--10905},
doi = {10.1021/acs.inorgchem.5c00894}
}
EUVIMED